Epigenetic inactivation of the human sprouty2 (hSPRY2) homologue in prostate cancer
- 14 February 2005
- journal article
- Published by Springer Science and Business Media LLC in Oncogene
- Vol. 24 (13), 2166-2174
- https://doi.org/10.1038/sj.onc.1208371
Abstract
Abnormal signalling events mediated by receptor tyrosine kinases (RTKs) contribute to human carcinogenesis. Sprouty2 (Spry2) is a key antagonistic regulator of RTK signalling and suppression of its expression or function may facilitate proliferation and angiogenesis. Using prostate cancer (CaP) as a model, we investigated the significance of Spry2 in human malignancy. We observed downregulated Spry2 expression in invasive CaP cell lines and high-grade clinical CaP (compared to benign prostatic hyperplasia (BPH) and well-differentiated tumours, P=0.041). A large CpG island is associated with hSPRY2, and extensive hypermethylation of this CpG island was observed in 76-82% of high-grade CaP, while control BPH tissues were predominantly unmethylated (P=0.0005). Furthermore, suppressed Spry2 expression correlated with methylation of the CpG region in clinical samples (P=0.004) and treatment with 5-aza-2'-deoxycytidine reactivated Spry2 expression in LNCaP and PC-3M cells. hSPRY2 maps to the long arm of chromosome 13 (13q31.1), where loss of heterozygosity (LOH) has been reported. We found no evidence of mutation; however, we demonstrated 27-40% LOH using flanking markers to hSPRY2. Hence, while biallelic epigenetic inactivation of hSPRY2 represents the main genetic event in prostate carcinogenesis, the observed 27-40% LOH presents evidence of hemizygous deletion with the remaining allele hypermethylated. We therefore propose hSPRY2 as a potential tumour suppressor locus in CaP.Keywords
This publication has 21 references indexed in Scilit:
- Escape from Cbl-mediated downregulation: A recurrent theme for oncogenic deregulation of receptor tyrosine kinasesCancer Cell, 2003
- Split personalities: the agonistic antagonist SproutyNature, 2003
- Negative receptor signallingCurrent Opinion in Cell Biology, 2003
- The Cysteine-Rich Sprouty Translocation Domain Targets Mitogen-Activated Protein Kinase Inhibitory Proteins to Phosphatidylinositol 4,5-Bisphosphate in Plasma MembranesMolecular and Cellular Biology, 2002
- Sprouty1 and Sprouty2 provide a control mechanism for the Ras/MAPK signalling pathwayNature, 2002
- Comprehensive analysis of CpG islands in human chromosomes 21 and 22Proceedings of the National Academy of Sciences of the United States of America, 2002
- Sprouty2 Inhibits the Ras/MAP Kinase Pathway by Inhibiting the Activation of RafPublished by Elsevier BV ,2002
- The Role of DNA Methylation in Mammalian EpigeneticsScience, 2001
- FGF8 over-expression in prostate cancer is associated with decreased patient survival and persists in androgen independent diseaseOncogene, 1999
- Expression of Fibroblast Growth Factors (FGFs) and FGF Receptors in Human ProstateJournal of Urology, 1997